These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16153396)

  • 1. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
    Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
    Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
    Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplotypes in the 5'-untranslated region of the CYP1A2 gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism.
    Gervasini G; Ghotbi R; Aklillu E; San Jose C; Cabanillas A; Kishikawa J; Benitez J; Carrillo JA
    Environ Mol Mutagen; 2013 Mar; 54(2):124-32. PubMed ID: 23138776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
    Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
    Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
    Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
    Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.
    Gunes A; Ozbey G; Vural EH; Uluoglu C; Scordo MG; Zengil H; Dahl ML
    Pharmacogenomics; 2009 May; 10(5):769-78. PubMed ID: 19450128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
    Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
    Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
    Liang L; Sun C; Liao XP; Xiao F; Chen XD; Huang SX; Tang XL; Wen GQ; Long ZG; Wang XY; Liu GX; Cheng S; Cai WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):316-9. PubMed ID: 16767673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.
    B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S
    Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytochrome P4501A2.
    Landi MT; Sinha R; Lang NP; Kadlubar FF
    IARC Sci Publ; 1999; (148):173-95. PubMed ID: 10493258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
    Bilgen T; Tosun O; Luleci G; Keser I
    Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
    Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
    Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
    Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
    Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
    Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
    Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.